We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $468M Turnover 12.5%
1-Year Est. Return 6.67%
This Fund
S&P 500
This Quarter Est. Return
+3.08%
1 Year Est. Return
+6.67%
3 Year Est. Return
+57.25%
5 Year Est. Return
+83.16%
10 Year Est. Return
+253.32%
AUM
$464M
AUM Growth
+$254K
Cap. Flow
-$11.5M
Cap. Flow %
-2.48%
Top 10 Hldgs %
46.69%
Holding
69
New
–
Increased
32
Reduced
23
Closed
5
Avg Time Held
2.5 years
Top 10 Avg Time Held
1.3 years
Top 20 Avg Time Held
1.6 years

Top Buys

Rank Stock Value
1
GNTX icon
Gentex
GNTX
+$5.51M
2
WBA icon
Walgreens Boots Alliance
WBA
+$4.42M
3
PEP icon
PepsiCo
PEP
+$2.84M
4
WFC icon
Wells Fargo
WFC
+$1.71M
5
COL
Rockwell Collins
COL
+$1.67M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$14.9M
2
VZ icon
Verizon
VZ
+$9.42M
3
BHI
Baker Hughes
BHI
+$3.91M
4
BAX icon
Baxter International
BAX
+$3.16M
5
SYT
Syngenta Ag
SYT
+$2.5M

Sector Composition

Rank Sector Weight
1 Healthcare 29.4%
2 Technology 18.16%
3 Industrials 17.16%
4 Financials 12.21%
5 Consumer Staples 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
KHC icon
51
The Kraft Heinz Company
KHC
$28.1B
$1.58M 0.34%
18,418
– –
2015 Q3
7 quarters
WMT icon
52
Walmart Inc
WMT
$943B
$1.51M 0.33%
59,850
– –
2013 Q2
16 quarters
CPA icon
53
Copa Holdings
CPA
$5.43B
$1.41M 0.3%
12,050
+100
+0.8% +$11.5K
2015 Q2
8 quarters
VIV icon
54
Telefônica Brasil
VIV
$20B
$1.23M 0.27%
91,482
+800
+0.9% +$11.5K
2013 Q3
15 quarters
BDX icon
55
Becton Dickinson
BDX
$52.2B
$1.23M 0.26%
6,458
– –
2013 Q2
16 quarters
SNY icon
56
Sanofi
SNY
$97.3B
$1.14M 0.25%
23,850
– –
2015 Q4
6 quarters
ABBV icon
57
AbbVie
ABBV
$504B
$890K 0.19%
12,275
– –
2013 Q2
16 quarters
SSL icon
58
Sasol
SSL
$10.5B
$759K 0.16%
27,169
+70
+0.3% +$2.08K
2013 Q3
15 quarters
MMM icon
59
3M
MMM
$85B
$677K 0.15%
3,892
-239
-6% -$40K
2013 Q2
16 quarters
ABT icon
60
Abbott
ABT
$181B
$624K 0.13%
12,843
-560
-4% -$25.3K
2013 Q2
16 quarters
XOM icon
61
ExxonMobil
XOM
$736B
$608K 0.13%
7,537
– –
2013 Q2
16 quarters
PG icon
62
Procter & Gamble
PG
$370B
$599K 0.13%
6,877
-600
-8% -$52.9K
2013 Q2
16 quarters
CHL
63
DELISTED
China Mobile Limited
CHL
$530K 0.11%
9,983
+90
+0.9% +$4.89K
2013 Q3
15 quarters
PTR
64
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$452K 0.1%
7,382
+80
+1% +$5.42K
2013 Q3
15 quarters
CAH icon
65
Cardinal Health
CAH
$58.8B
– –
-18,053
Closed -$1.47M –
IBM icon
66
IBM
IBM
$219B
– –
-1,862
Closed -$310K –
JPM icon
67
JPMorgan Chase
JPM
$902B
– –
-2,403
Closed -$211K –
USB icon
68
US Bancorp
USB
$91.5B
– –
-6,533
Closed -$336K –
SYT
69
DELISTED
Syngenta Ag
SYT
– –
-28,224
Closed -$2.5M –
1 2
3

Similar funds

GC
Guidance Capital Lousville, Kentucky $468M AUM 26.09% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
THC
Truffle Hound Capital Bethesda, Maryland $468M AUM 42.57% 1-Year Est. Return
STCG
Speece Thorson Capital Group Minnetonka, Minnesota $468M AUM 19.67% 1-Year Est. Return
BAM
Brave Asset Management Summit, New Jersey $467M AUM 33.05% 1-Year Est. Return
TOCUITCONY
Trustees of Columbia University in the City of New York New York $468M AUM 20.53% 1-Year Est. Return
MB
Mizuho Bank Tokyo, Japan $467M AUM 24.01% 1-Year Est. Return
TAM
Talaria Asset Management Melbourne, Australia $467M AUM 14.07% 1-Year Est. Return

Foyston, Gordon, & Payne's Q2 2017 Portfolio in Review

As of Q2 2017, Foyston, Gordon, & Payne held 69 positions worth $464M, up 0.05% from $464M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Foyston, Gordon, & Payne's Q2 2017 filing shows 32 increased, 23 reduced and 5 closed positions. The largest sale was Medtronic, an estimated $14.9M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 30% a quarter earlier, followed by Technology and Industrials.

  • Foyston, Gordon, & Payne added most to Gentex in Q2 2017, an estimated $5.51M increase.
  • Foyston, Gordon, & Payne's biggest Q2 2017 reduction was Medtronic, cutting an estimated $14.9M.
  • Foyston, Gordon, & Payne fully exited Syngenta Ag in Q2 2017, selling an estimated $2.5M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 47% of its $464M portfolio in Q2 2017.
  • Foyston, Gordon, & Payne opened 0 new positions and closed 5 in Q2 2017.
  • Foyston, Gordon, & Payne's portfolio value rose 0.05% quarter-over-quarter to $464M.

Based on Foyston, Gordon, & Payne's 13F filing for Q2 2017, filed 14 Aug 2017.